[HTML][HTML] Cyclophosphamide exposure causes long-term detrimental effect of oocytes developmental competence through affecting the epigenetic modification and …

W Yang, Y Ma, J Jin, P Ren, H Zhou, S Xu… - Frontiers in Cell and …, 2021 - frontiersin.org
Cyclophosphamide (CTX) is widely used in various cancer therapies and in
immunosuppression, and patients can still have babies after CTX chemotherapy. CTX …

Cyclophosphamide Exposure Causes Long-Term Detrimental Effect of Oocytes Developmental Competence Through Affecting the Epigenetic Modification and …

W Yang, Y Ma, J Jin, P Ren, H Zhou… - Frontiers in cell …, 2021 - pubmed.ncbi.nlm.nih.gov
Cyclophosphamide (CTX) is widely used in various cancer therapies and in
immunosuppression, and patients can still have babies after CTX chemotherapy. CTX …

Cyclophosphamide Exposure Causes Long-Term Detrimental Effect of Oocytes Developmental Competence Through Affecting the Epigenetic Modification and …

W Yang, Y Ma, J Jin, P Ren, H Zhou, S Xu, Y Zhang… - 2021 - agris.fao.org
Cyclophosphamide (CTX) is widely used in various cancer therapies and in
immunosuppression, and patients can still have babies after CTX chemotherapy. CTX …

Cyclophosphamide Exposure Causes Long-Term Detrimental Effect of Oocytes Developmental Competence Through Affecting the Epigenetic Modification and …

W Yang, Y Ma, J Jin, P Ren, H Zhou, S Xu… - Frontiers in Cell and …, 2021 - europepmc.org
Cyclophosphamide (CTX) is widely used in various cancer therapies and in
immunosuppression, and patients can still have babies after CTX chemotherapy. CTX …

[HTML][HTML] Cyclophosphamide Exposure Causes Long-Term Detrimental Effect of Oocytes Developmental Competence Through Affecting the Epigenetic Modification …

W Yang, Y Ma, J Jin, P Ren, H Zhou, S Xu… - Frontiers in Cell and …, 2021 - ncbi.nlm.nih.gov
Cyclophosphamide (CTX) is widely used in various cancer therapies and in
immunosuppression, and patients can still have babies after CTX chemotherapy. CTX …